A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

February 2, 2024

Study Completion Date

February 2, 2024

Conditions
Ulcerative ColitisCrohn Disease
Interventions
DRUG

Vedolizumab IV

Vedolizumab IV infusion

Trial Locations (17)

110001

Dr. Ram Manohar Lohia Hospita Hospital, New Delhi

110002

Maulana Azad Medical college & Associated G B Pant Hospital, New Delhi

110029

All India Institute of Medical Sciences, New Delhi

141001

Dayanand Medical College and Hospital, Ludhiana

226003

King George's Medical University, Lucknow

380054

Gastroplus Digestive Disease Centre Pvt.Ltd, Ahmedabad

395002

Surat Institute of Digestive Sciences, Surat

440010

Midas Multispeciality Hospital, Nagpur

500003

Yashoda Hospitals, Secunderabad

500012

Osmania General Hospital, Hyderabad

500058

Deccan College of Medical Sciences, Hyderabad

500082

Asian Institute of Gastroenterology, Hyderabad

522001

Government General Hospital, Guntur

560002

Banglore Medical College & Research Institute, Bangalore

641005

VGM Hospital- Institute of Gastroenterology, Coimbatore

781006

Institute of Gastroenterology and Liver Disease Dispur Hospitals, Guwahati

800014

Indira Gandhi Institute of Medical Sciences, Patna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY